Cell culture in autologous fibrin scaffolds for applications in tissue engineering

Experimental Cell Research

Volumn 322, Issue 1, 2014, Pages 1-11

  De la Puente, Pilar ^a   Ludeña, Dolores ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Autologous; Cell culture; Fibrin scaffolds; Fibrinogen; Tissue engineering

Indexed keywords

BIOMATERIAL; FIBRIN; FIBRIN GLUE; FIBRINOGEN; TISSUE SCAFFOLD;

ADIPOSE TISSUE; BIODEGRADABILITY; BONE; CARTILAGE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CHEMICAL COMPOSITION; DRUG DELIVERY SYSTEM; EXTRACELLULAR MATRIX; EYE; FIBRIN CLOT; HEART; HUMAN; LIGAMENT; LUNG PARENCHYMA; MUSCLE TISSUE; NERVOUS TISSUE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN; TENDON; TISSUE ENGINEERING; VASCULAR TISSUE;

AUTOLOGOUS; CELL CULTURE; FIBRIN SCAFFOLDS; FIBRINOGEN; TISSUE ENGINEERING;

ANIMALS; AUTOGRAFTS; BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; FIBRIN; FIBRIN TISSUE ADHESIVE; HUMANS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84893748060     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.12.017     Document Type: Review

References (99)

1. de la Puente P., Ludeña D., Fernández A., Aranda J.L., Varela G., Iglesias J. Autologous fibrin scaffolds cultured dermal fibroblasts and enriched with encapsulated bFGF for tissue engineering. J. Biomed. Mater. Res. Part A 2011, 99:648-654.
2. Yang S., Leong K.F., Du Z., Chua C.K. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng. 2001, 7:679-689.
3. Klin B., Weinberg M., Vinograd I., Sandbank J., Siman-Tov Y., Astachov L., Ayalon O., Rochkind S., Shahar A., Nevo Z. Experimental repair of tracheal defects using a new biodegradable membrane. J. Laparoendosc. Adv. Surg. Tech. 2007, 17:342-349.
4. Walles T., Giere B., Hofmann M., Schanz J., Hofmann F., Mertsching H., Macchiarini P. Experimental generation of a tissue-engineered functional and vascularized trachea. J. Thorac. Cardiovasc. Surg. 2004, 128:900-906.
5. Macedo A., Fadel E., Mazmanian G.M., Montpréville V., German-Fattal M., Mussot S., Chapelier A., Dartevelle P.G. Heterotopic en bloc tracheobronquial transplantation with direct revascularization in pigs. J. Thorac. Cardiovasc. Surg. 2004, 127:1593-1601.
6. Liu C., Xia Z., Czernuszka J.T. Design and development of three-dimensional scaffolds for tissue engineering. Trans. IChemE, Part A: Chem. Eng. Res. Des. 2007, 85:1051-1064.
7. Li Z., Ramay H.R., Hauch H.D., Xiao D., Zhang M. Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials 2005, 26:3919-3928.
8. Ahmed T.A., Dare E.V., Hincke M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng. Part B 2008, 14:199-215.
9. Gunatillake P.A., Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur. Cell Mater. 2003, 5:1-16.
10. Ng K.W., Khor H.L., Hutmacher D.W. In vitro characterization of natural and synthetic dermal matrices cultured with human dermal fibroblasts. Biomaterials 2004, 25:2807-2818.
11. Lynn A.K., Yannas Bonfield W. Antigenicity and immunogenicity of collagen. J. Biomed. Mater. Res. Part B 2004, 71B:343-354.
12. Ma L., Gao C., Mao Z., Zhou J., Shen J. Enhanced biological stability of collagen porous scaffolds by using amino acids as novel cross-linking bridges. Biomaterials 2004, 25:2997-3004.
13. Rault I., Frei V., Herbage D., Abdul-Marak N., Hue A. Evaluation of different chemical methods for cross-linking collagen gel, films and sponges. J. Mater. Sci. - Mater. Med. 1996, 7:215-221.
14. Sung H.J., Johnson C.E., Lessner S.M., Magid R., Drury D.N., Galis Z.S. Matrix metalloproteinase 9 facilitates collagen remodeling and angiogenesis for vascular constructs. Tissue Eng. 2005, 11:267-276.
15. Chevallay B., Herbage D. Collagen-based biomaterials as 3D scaffold for cell cultures: applications for tissue engineering and gene therapy. Med. Biol. Eng. Comput. 2000, 38:211-218.
16. Jockenhoevel S., Zund G., Hoerstrup S.P., Chalabi K., Sachweh J.S., Demircan L., Messmer B.J., Turina M. Fibrin gel-advantages of a new scaffold in cardiovascular tissue engineering. Eur. J. Cardithorac. Surg. 2001, 19:424-430.
17. Ye Q., Zünd G., Benedikt P., Jockenhoevel S., Hoerstrup S.P., Sakyama S., Hubbell J.A., Turina M., Eur J. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Cardiothorac. Surg. 2000, 17:587-591.
18. Rosso F., Marino G., Giordano A., Barbarisi M., Parmeggiani D., Barbarisi A. Smart materials as scaffolds for tissue engineering. J. Cell Physiol. 2005, 203:465-470.
19. Anderson J.M. Biological responses to materials. Annu. Rev. Mater. Res. 2001, 31:81-110.
20. Mosesson M.W. Fibrinogen and fibrin polymerization and functions. Blood Coagul. Fibrinolysis 1999, 10(Suppl. 1):S45-S48.
21. Lauricella A.M. Fibrin network variability. Acta Bioquim Clin Latinoam 2007, 41:7-19.
22. Weisel J.W. Fibrinogen and fibrin. Adv. Protein Chem. 2005, 70:247-299.
23. Siebenlist K.R., Meh D.A., Mosesson M.W. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains. Biochemistry 1996, 35:10448-10453.
24. Mosesson M.W. Fibrinogen and fibrin structure and functions. J. Thromb. Haemost. 2005, 3:1894-1904.
25. Clark R.A. Fibrin is a many splendored thing. J. Invest. Dermatol. 2003, 121:xxi-xxii.
26. Henschen A., McDonagh J. Blood Coagulation 1986, 171. Elsevier, Amsterdam.
27. Weisel J.W. Structure of fibrin: impact on clot stability. J. Thromb. Haemost. 2007, 5:116-124.
28. Makogonenko E., Tsurupa G., Ingham K., Medved L. Interaction of fibrin (ogen) with fibronectin: further characterization and localization of the fibronectin-binding site. Biochemistry 2002, 41:7907-7913.
29. Preissner K.T., Jenne D. Vitronectin: a new molecular connection in haemostasis. Thromb. Haemost. 1991, 66:189-194.
30. Sahni A., Francis C.W. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000, 96:3772-3778.
31. Bergel S. Überwirkungen des fibrins. Dtsch. Med. Wochenschr. 1909, 35:633.
32. Cronkite E.P., Lozner E.L., Deaver J.M. Use of thrombin and fibrinogen in skin grafting. J. Am. Med. Assoc. 1944, 124:976-978.
33. Jackson M.R. Fibrin sealants in surgical practice: an overview. Am. J. Surg. 2001, 182:1S-7S.
34. Kjaergard H.K., Velada J.L., Pedersen J.H., Fleron H., Hollingsbee D.A. Comparative kinetics of polymerization of three fibrin sealants and influence of timing of tissue adhesion. Thromb. Res. 2000, 98:221-228.
35. Gibble J.W., Ness P.M. Fibrin glue: the perfect operative sealantα. Trans. Fusion 1990, 30:741-747.
36. Joch C. The safety of fibrin sealants. Cardiovasc. Surg. 2003, 11:23-28.
37. Dodds R.Y. Current viral risks of blood and blood products. Ann. Med. 2000, 32:469-474.
38. Tredwell S.J., Sawatzky B. The use of fibrin sealant to reduce blood loss during Cotrel-Dubousset instrumentation for idiopathic scoliosis. Spine 1990, 15:913-915.
39. McGill V., Kowal-Vern A., Lee M., Greenhalgh D., Gomperts E., Bray G., Gamelli R. Use of fibrin sealant in thermal injury. J. Burn Care Rehabil. 1997, 18:429-434.
40. Sierra D.H., Eberhardt A.W., Lemons J.E. Failure characteristics of multiple-component fibrin-based adhesives. J. Biomed. Mater. Res. 2002, 59:1-11.
41. Linnes M.P., Ratner B.D., Giachelli C.M. A fibrinogen-based precision microporous scaffold for tissue engineering. Biomaterials 2007, 28:5298-5306.
42. Jackson M.R., MacPhee M.J., Drohan W.N., Alving B.M. Fibrin sealant: current and potential clinical applications. Blood Coagul. Fibrinolysis 1996, 10:737-746.
43. Briganti E., Spiller D., Mirtelli C., Kull S., Counoupas C., Losi P., Senesi S., Di Stefano R., Soldani G. A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenic growth factors. J. Controlled Release 2010, 142:14-21.
44. Zisch A.H., Schenk U., Schense J.C., Sakiyama-Elbert S.E., Hubbell J.A. Covalently conjugated VEGF-fibrin matrices for endothelialization. J. Controlled Release 2001, 72:101-113.
45. Bensaid W., Triffitt J.T., Blanchat C., Oudina K., Sedel L., Petite H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 2003, 24:2497-2502.
46. Barsotti M.C., Magera A., Armani C., Chiellini F., Felice F., Dinucci D., Piras A.M., Minnocci A., Solaro R., Soldani G., Balbarini A., Di Stefano R. Fibrin acts as biomimetic niche inducing both differentiation and stem cell marker expression of early human endothelial progenitor cells. Cell Prolif. 2011, 44:33-48.
47. de la Puente P., Ludeña D., López M., Ramos J., Iglesias J. Differentiation within autologous fibrin scaffolds of porcine dermal cells with the mesenchymal stem cell phenotype. Exp. Cell Res. 2013, 319:144-152.
48. Yang Y.I., Seol D.L., Kim H.I., Cho M.H., Lee S.J. Composite fibrin and collagen scaffold to enhance tissue regeneration and angiogenesis. Curr. Appl. Phys. 2007, 7S1:e103-e107.
49. Catelas I., Sese N., Wu B.M., Dunn J.C., Helgerson S., Tawil B. Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro. Tissue Eng. 2006, 12:2385-2396.
50. Cox S., Cole M., Tawil B. Behaviour of human dermal fibroblasts in three dimensional fibrin clots: dependence on fibrinogen and thrombin concentration. Tissue Eng. 2004, 10:942-954.
51. Siedentop K.H., Park J.J., Shah A.N., Bhattacharyya T.K., O'Grady K.M. Safety and efficacy of currently available fibrin tissue adhesives. Am. J. Otolaryngol. 2001, 22:230-235.
52. Perka C., Schultz O., Spitzer R.S., Lindenhayn K., Burmester G.R., Sittinger M. Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits. Biomaterials 2000, 21:1145-1153.
53. Borges J., Mueller M.C., PAdron N.T., Tegtmeier F., Lang E.M., Stark G.B. Engineered adipose tissue supplied by functional microvessels. Tisuue Eng. 2003, 9:1263-1270.
54. Cho S.W., Kim S.S., Rhie J.W., Cho H.M., Choi C.Y., Kim B.S. Engineering of volume-stable adipose tissue. Biomaterials 2005, 26:3577-3585.
55. Zhang Y.S., Gao J.H., Lu F., Zhu M. Adipose tissue engineering with human adipose-derived stem cells and fibrin glue injectable scaffold. Zhonghua Yi Xue Za Zhi 2008, 88:2705-2709.
56. Yamada Y., Boo J.S., Ozawa R., Nagasaka T., Okazaki Y., Hata K., Ueda M. Bone regeneration following injection of mesenchymal stem cells and fibrin glue with a biodegradable scaffold. J. Craniomaxillofac. Surg. 2003, 31:27-33.
57. Zhou H., Xu H.H. The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds for bone tissue engineering. Biomaterials 2011, 32:7503-7513.
58. Birla R.K., Borschel G.H., Dennis R.G., Brown D.L. Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng. 2005, 11:803-813.
59. Weber M., Heta E., Moreira R., Gesche V.N., Schermer T., Frese J., Jockenhoevel S., Mela P. Tissue-engineered fibrin-based heart valve with a tubular leaflet design. Tissue Eng. Part C 2013, (Oct 19). 10.1089/ten.tec.2013.0258.
60. Eyrich D., Brandl F., Appel B., Wiese H., Maier G., Wenzel M., Staudenmaier R., Goepferich A., Blunk T. Long-term stable fibrin gels for cartilage engineering. Biomaterials 2007, 28:55-65.
61. Li B., Yang J., Ma L., Li F., Tu Z., Gao C. Fabrication of poly(lactide-co-glycolide) scaffold filled with fibrin gel, mesenchymal stem cells, and poly(ethylene oxide)-b-poly(l-lysine)/TGF-β1 plasmid DNA complexes for cartilage restoration in vivo. J. Biomed. Mater. Res. Part A 2013, 101:3097-3108.
62. Ahmed T.A., Griffith M., Hincke M. Characterization and inhibition of fibrin hydrogel-degrading enzymes during development of tissue engineering scaffolds. Tissue Eng. 2007, 13:1469-1477.
63. Montana M., Tabélé C., Curti C., Terme T., Rathelot P., Gensollen S., Vanelle P. Organic glues or fibrin glues from pooled plasma: efficacy, safety and potential as scaffold delivery systems. J. Pharm. Pharm. Sci. 2012, 15:124-140.
64. Willerth S.M., Rader A., Sakiyama-Elbert S.E. The effect of controlled growth factor delivery on embryonic stem cell differentiation inside fibrin scaffolds. Stem Cell Res. 2008, 1:205-218.
65. Zurita M., Aguayo C., Vaquero J. Usefulness of platelet-rich plasma as a scaffold for stromal cells in regenerative therapies of the Nervous System. Trauma Fund Mapfre 2011, 22:38-46.
66. Mandal B.B., Kundu S.C. Osteogenic and adipogenic differentiation of rat bone marrow cells on non-mulberry and mulberry silk gland fibroin scaffolds. Biomaterials 2009, 30:5019-5030.
67. Schneider R.K., Puellen A., Kramann R., Raupach K., Bornemann J., Knuechel R., Pérez-Bouza A., Neuss S. The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodeling in three-dimensional collagen scaffolds. Biomaterials 2010, 31:467-480.
68. Rentsch C., Rentsch B., Breier A., Hofmann A., Manthey S., Scharnweber D., Biewener A., Zwipp H. Evaluation of the osteogenic potential and vascularization of 3D poly(3)hydroxybutirate scaffolds subcutaneously implanted in nude rats. J. Biomed. Mater. Res. 2010, 92A:185-195.
69. Bosnakovski D., Mizuno M., Kim G, Ishiguro T, Okumura M, Iwanaga T, Kadosawa T, Fujinaga T. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells in pellet cultural system. Exp. Hematol. 2004, 32:502-509.
70. Huang Y.C., Dennis R.G., Larkin L., Baar K. Rapid formation of functional muscle in vitro using fibrin gels. J. Appl. Physiol. 2005, 98:706-713.
71. Page R.L., Malcuit C., Vilner L., Vojtic I., Shaw S., Hedblom E., Hu J., Pins G.D., Rolle M.W., Dominko T. Restoration of skeletal muscle defects with adult human cells delivered on fibrin microthreads. Tissue Eng. Part A 2011, 17:2629-2640.
72. Liu J., Xu H.H., Zhou H., Weir M.D., Chen Q., Trotman C.A. Human umbilical cord stem cell encapsulation in novel macroporous and injectable fibrin for muscle tissue engineering. Acta Biomater. 2013, 9:4688-4697.
73. Sakiyama S.E., Schense J.C., Hubbell J.A. Incorporation of heparin-binding peptide into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering. FASEB J. 1999, 13:2214-2224.
74. Willerth S.M., Arendas K.J., Gottlieb D.I., Sakiyama-Elbert S.E. Optimization of fibrin scaffolds for differentiation scaffolds for differentiation of murine embryonic stem cells into neural lineage cells. Biomaterials 2006, 27:5990-6003.
75. Han B., Schwab I.R., Madsen T.K., Isseroff R.R. A fibrin-based bioengineered ocular surface with human corneal epithelial stem cells. Cornea 2002, 21:505-510.
76. Alaminos M., Del Carmen Sanchez-Quevedo M., Munoz-Avila J.I., Serrano D., Medialdea S., Carreras I., Campos A. Construction of a complete rabbit cornea substitute using fibrin-agarose scaffold. Invest. Ophtalmol. Vis. Sci. 2006, 47:3311-3317.
77. Kim D.Y., Pyun J., Choi J.W., Kim J.H., Lee J.S., Shin H.A., Kim H.J., Lee H.N., Min B.H., Cha H.E., Kim C.H. Tissue-engineered allograft tracheal cartilage using fibrin/hyaluronan composite gel and its in vivo implantation. Laryngoscope 2010, 120:30-38.
78. Cornelissen C.G., Dietrich M., Krüger S., Spillner J., Schmitz-Rode T., Jockenhoevel S. Fibrin gel as alternative scaffold for respiratory tissue engineering. Ann. Biomed. Eng. 2012 Mar, 40(3):679-687.
79. Geer D.J., Swartz D.D., Andreadis S.T. Fibrin promotes in a three-dimensional in vitro model of wound regeneration. Tissue Eng. 2002, 8:787-798.
80. Carriel V., Garzón I., Jiménez J.M., Oliveira A.C., Arias-Santiago S., Campos A., Sánchez-Quevedo M.C., Alaminos M. Epithelial and stromal developmental patterns in a novel substitute of the human skin generated with fibrin-agarose biomaterials. Cells Tissues Organs 2012, 196:1-12.
81. Hankemeier S., van Griensven M., Ezechieli M., Barkhausen T., Austin M., Jagodzinski M., Meller R., Bosch U., Krettek C., Zeichen J. Tissue engineering of tendons and ligaments by human bone marrow stromal cells in a liquid fibrin matrix in immunodeficient rats: results of a histologic study. Arch. Orthop. Trauma Surg. 2007, 127:815-821.
82. Paxton J.Z., Wudebwe U.N., Wang A., Woods D., Grover L.M. Monitoring sinew contraction during formation of tissue-engineered fibrin-based ligament constructs. Tissue Eng. Part A 2012, 18:1596-1607.
83. Cummings C.L., Gawlitta D., Nerem R.M., Stegemann J.P. Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. Biomaterials 2004, 25:3699-3706.
84. Lesman A., Koffler J., Atlas R., Blinder Y.J., Kam Z., Levenberg S. Engineering vessel-like networks within multicellular fibrin-based constructs. Biomaterials 2011, 32:7856-7869.
85. Silver F.H., Wang M.C., Pins G.D. Preparation and use of fibrin glue in surgery. Biomaterials 1995, 16:891-903.
86. Reiss R.F., Oz M.C. Autologous fibrin glue: production and clinical use. Transfus. Med. Rev. 1996, 10:85-92.
87. Alston S.M., Solen K.A., Sukavaneshvar S., Mohammad S.F. New method to prepare autologous fibrin glue on demand. Transl. Res. 2007, 149:187-195.
88. Zhao H., Ma L., Zhou J., Mao Z., Gao C., Shen J. Fabrication and physical and biological properties of fibrin gel derived from human plasma. Biomed. Mater. 2008, 3:015001.
89. Vavken P., Joshi S.M., Murray M.M. Fibrin concentration affects ACL fibroblast proliferation and collagen synthesis. Knee 2011, 18:42-46.
90. Wang M.-C., Pins G.D., Silver F.H. Preparation of fibrin glue: the effects of calcium chloride and sodium chloride. Mater. Sci. Eng. 1995, C3:131-135.
91. Le Guehennec L., Goyenvalle E., Aguado E., Pilet P., Spaethe R., Daculsi G. Influence of calcium chloride and aprotinin in the in vivo biological performance of a composite combining biphasic calcium phosphate granules and fibrin sealant. J. Mater. Sci.-Mater. Med. 2007, 18(8):1489-1495.
92. Cholewinski E., Dietrich M., Flanagan T.C., Schmitz-Rode T., Jockenhoevel S. Tranexamic acid-an alternative to aprotinin in fibrin-based cardiovascular tissue engineering. Tissue Eng. Part A. 2009, 15(11):3645-3653.
93. Demol J., Eyckmans J., Roberts S.J., Luyten F.P., Van Oosterwyck H. Does tranexamic acid stabilised fibrin support the osteogenic differentiation of human periosteum derived cellsα. Eur. Cell Mater. 2011, 21:272-285.
94. Ho W., Tawil B., Dunn J.C. Wu Bm. The behaviour of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Eng. 2006, 12:1587-1595.
95. Rowe S.L., Lee S., Stegemann J.P. Influence of thrombin concentration on the mechanical and morphological properties of cell-seeded fibrin hydrogels. Acta Biomater. 2007, 3:59-67.
96. Shiba Y., Yamada S., Kanno Y. Survival of 3T3-L1 cells induced by fibroblast growth factor depends on cell density and adhesion to the substratum. Cell Struct. Funct. 1989, 14:473-483.
97. Gailit J., Clarke C., Newman D., Tonnesen M.G., Mosesson M.W., Clark R.A. Human fibroblasts bind directly to fibrinogen at RGD sites through integrin alpha(v)beta3. Exp. Cell Res. 1997, 232:118-126.
98. Hale B.W., Goodrich L.R., Frisbie D.D., McIlwraith C.W., Kisiday J.D. Effect of scaffold dilution on migration of mesenchymal stem cells from fibrin hydrogels. Am. J. Vet. Res. 2012, 73:313-318.
99. Jeon O., Ryu S., Chung J.H., Kim B.S. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J. Control Release 2005, 105:249-259.